MAA
TEVA icon

Matrix Asset Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Matrix Asset Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-261,000
Closed -$9.46M – 72
2016
Q4 		$9.46M Buy
261,000
+1,742
+0.7% +$69.6K 1.6% 28
2016
Q3 		$11.9M Buy
259,258
+23,786
+10% +$1.24M 2.1% 20
2016
Q2 		$11.8M Buy
235,472
+5,170
+2% +$275K 2.3% 17
2016
Q1 		$12.3M Buy
230,302
+3,353
+1% +$197K 2.43% 15
2015
Q4 		$14.9M Sell
226,949
-121,350
-35% -$7.5M 2.87% 10
2015
Q3 		$19.7M Sell
348,299
-14,559
-4% -$944K 2.81% 13
2015
Q2 		$21.4M Sell
362,858
-5,245
-1% -$324K 2.69% 17
2015
Q1 		$22.9M Buy
368,103
+4,389
+1% +$255K 2.65% 18
2014
Q4 		$20.9M Buy
363,714
+252
+0.1% +$14K 2.36% 24
2014
Q3 		$19.5M Sell
363,462
-1,710
-0.5% -$90.6K 2.27% 27
2014
Q2 		$19.1M Sell
365,172
-5,305
-1% -$271K 2.18% 27
2014
Q1 		$19.6M Sell
370,477
-54,984
-13% -$2.54M 2.34% 26
2013
Q4 		$17.1M Sell
425,461
-25,153
-6% -$990K 2.07% 26
2013
Q3 		$17M Buy
450,614
+5,355
+1% +$209K 2.3% 22
2013
Q2 		$17.5M Buy
+445,259
New +$17.3M 2.44% 24

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Matrix Asset Advisors's TEVA Position: Q1 2017 in Review

Matrix Asset Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 261,000 shares — an estimated $9.46M sold.

Matrix Asset Advisors first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $22.9M in Q1 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Matrix Asset Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Matrix Asset Advisors sold 261,000 Teva Pharmaceuticals shares in Q1 2017, an estimated $9.46M.
  • Matrix Asset Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Matrix Asset Advisors's Teva Pharmaceuticals position peaked at $22.9M in Q1 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Matrix Asset Advisors's 13F filing for Q1 2017, filed 10 May 2017.